JAMEY KIM: Open Payments
NPI 1235706672 · PORT JEFFERSON STATION, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 24 payments from 10 companies in 2025. Trend: 2023 $138 · 2024 $277 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 4 | $118 |
| Otsuka America Pharmaceutical, Inc. | 5 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $102 |
| Novartis Pharmaceuticals Corporation | 3 | $83 |
| Fresenius USA Manufacturing, Inc. | 2 | $46 |
| Amgen Inc. | 2 | $45 |
| Calliditas Therapeutics US Inc. | 1 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: JYNARQUE, Kerendia, Fabhalta, VELPHORO, TARPEYO, JARDIANCE, INJECTAFER, OTEZLA.
Industry payments across NY — which companies pay providers there.
